First-line ribociclib and endocrine therapy may be more effective than combined chemotherapy in aggressive breast cancer

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor-positive, HER2-negative, advanced breast cancer—including patients with visceral cris

Updated on: February 01,2024

First-line ribociclib and endocrine therapy may be more effective than combined chemotherapy in aggressive breast cancer

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor-positive, HER2-negative, advanced breast cancer—including patients with visceral cris

Updated on:February 01,2024

Researchers find possible cause for chemoresistance in bowel cancer

by Martin-Luther-Universität Halle-WittenbergAnalysis of IGF2BP2 targets in tumor and metastatic CRC tissues. A, B Cumulative plot of gene expression (log2 fold change) in primary (A) and metastatic (

Updated on: January 30,2024

Researchers find possible cause for chemoresistance in bowel cancer

by Martin-Luther-Universität Halle-WittenbergAnalysis of IGF2BP2 targets in tumor and metastatic CRC tissues. A, B Cumulative plot of gene expression (log2 fold change) in primary (A) and metastatic (

Updated on:January 30,2024

Researchers develop novel approach for predicting resistance against cancer therapy

by National University of SingaporeMultispectral microscopy with quantitative immunofluorescence is a state-of-the-art technology that can detect oncogenes simultaneously, allowing for the identi

Updated on: February 18,2024

Researchers develop novel approach for predicting resistance against cancer therapy

by National University of SingaporeMultispectral microscopy with quantitative immunofluorescence is a state-of-the-art technology that can detect oncogenes simultaneously, allowing for the identi

Updated on:February 18,2024

A two-for-one approach to boost melanoma immunotherapy

by Sanford Burnham Prebys Medical Discovery InstituteCredit: Unsplash/CC0 Public DomainNew research from Sanford Burnham Prebys has helped explain how melanoma evades the immune system and may gu

Updated on: February 03,2024

A two-for-one approach to boost melanoma immunotherapy

by Sanford Burnham Prebys Medical Discovery InstituteCredit: Unsplash/CC0 Public DomainNew research from Sanford Burnham Prebys has helped explain how melanoma evades the immune system and may gu

Updated on:February 03,2024

Using virtual biopsies to improve melanoma detection

by Andrea Leland,Colorado State UniversityCredit: Colorado State UniversityWith Skin Cancer Awareness Month upon us, Colorado State University researcher Jesse Wilson is accelerating research to

Updated on: March 09,2024

Using virtual biopsies to improve melanoma detection

by Andrea Leland,Colorado State UniversityCredit: Colorado State UniversityWith Skin Cancer Awareness Month upon us, Colorado State University researcher Jesse Wilson is accelerating research to

Updated on:March 09,2024

Repurposing heart drugs to target cancer cells

by MRC London Institute of Medical SciencesCredit: CC0 Public DomainSenescence is a cellular stress response that results in the stable growth arrest of old and damaged cells. The past decade has reve

Updated on: April 07,2024

Repurposing heart drugs to target cancer cells

by MRC London Institute of Medical SciencesCredit: CC0 Public DomainSenescence is a cellular stress response that results in the stable growth arrest of old and damaged cells. The past decade has reve

Updated on:April 07,2024

Tumors form temporary structures to avoid immunotherapy treatments

byeLifeTumor-reactive T cells induce transient cell-in-cell structure. (A) Mean percentage of cell-in-cell tumor formations following incubation of B16F10 cells with immune cells (n=4). (B) Repr

Updated on: January 22,2024

Tumors form temporary structures to avoid immunotherapy treatments

byeLifeTumor-reactive T cells induce transient cell-in-cell structure. (A) Mean percentage of cell-in-cell tumor formations following incubation of B16F10 cells with immune cells (n=4). (B) Repr

Updated on:January 22,2024

Novel therapeutic strategy against melanoma: Combined targeting of hedgehog signaling and BRD4

by Impact Journals LLCCombined targeting of SMO and BRD4 as a potential therapeutic strategy against melanoma. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28441A new editorial paper

Updated on: January 11,2024

Novel therapeutic strategy against melanoma: Combined targeting of hedgehog signaling and BRD4

by Impact Journals LLCCombined targeting of SMO and BRD4 as a potential therapeutic strategy against melanoma. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28441A new editorial paper

Updated on:January 11,2024

Expert second opinion improves reliability of melanoma diagnoses

by University of California, Los AngelesCredit: CC0 Public DomainGetting a reliable diagnosis of melanoma can be a significant challenge for pathologists. The diagnosis relies on a pathologist&#3

Updated on: April 07,2024

Expert second opinion improves reliability of melanoma diagnoses

by University of California, Los AngelesCredit: CC0 Public DomainGetting a reliable diagnosis of melanoma can be a significant challenge for pathologists. The diagnosis relies on a pathologist&#3

Updated on:April 07,2024

Sperm quality unaffected by one course of chemotherapy for early testicular cancer

by European Society for Medical OncologyHuman sperm stained for semen quality testing in the clinical laboratory. Credit: Bobjgalindo/WikipediaMen with early stage testicular cancer can safely re

Updated on: March 06,2024

Sperm quality unaffected by one course of chemotherapy for early testicular cancer

by European Society for Medical OncologyHuman sperm stained for semen quality testing in the clinical laboratory. Credit: Bobjgalindo/WikipediaMen with early stage testicular cancer can safely re

Updated on:March 06,2024

Shortages of essential medicines for pediatric cancer patients threaten outcomes

by Baylor College of MedicineCredit: CC0 Public DomainShortages of essential chemotherapy drugs for children undergoing cancer treatment has been an increasingly frequent obstacle for patients an

Updated on: March 06,2024

Shortages of essential medicines for pediatric cancer patients threaten outcomes

by Baylor College of MedicineCredit: CC0 Public DomainShortages of essential chemotherapy drugs for children undergoing cancer treatment has been an increasingly frequent obstacle for patients an

Updated on:March 06,2024

Fred Hutch researchers engineer complex immunotherapy that may target relapsing leukemia

by Fred Hutchinson Cancer Research CenterDr. Marie Bleakley, a pediatric oncologist and researcher at Fred Hutch, is advancing a new approach to genetically engineer T cells. Credit: Fred HutchOc

Updated on: March 06,2024

Fred Hutch researchers engineer complex immunotherapy that may target relapsing leukemia

by Fred Hutchinson Cancer Research CenterDr. Marie Bleakley, a pediatric oncologist and researcher at Fred Hutch, is advancing a new approach to genetically engineer T cells. Credit: Fred HutchOc

Updated on:March 06,2024